The Ministry of Health must complete the distribution of more than 400,000 units of rapid-acting insulin analogues by July 9. The medicine is used to treat type 1 diabetes and was acquired after failed negotiation attempts and risk of deficiency.

Delivery is expected due to the risk of shortages caused by worldwide shortages of insulin – Photo: Marcello Casal Jr/Agência Brasil/ND

Information taken from the portal R7. The federal government managed to get the doses after five months of negotiations with the pharmaceutical sector and after two failed attempts. This is due to the fact that in the previous trading sessions – in August last year and in January of this year – no offers were received.

The waiting for delivery is due to the risk of shortages caused by the worldwide shortage of the product. The load of 400,000 doses is added to the 1.3 million doses purchased on an emergency basis, which will supply the CMS and more than 60,000 people caring for the Unified Health System.

SK don’t know if he’ll get insulin

In Santa Catarina, the SES (Secretary of State for Health) stated that the Ministry of Health had not informed him whether it would be received, when and how many units of the drug would be received.

According to the Ministry of Health, the most consumed conventional insulins indicated for patients with type 2 diabetes and other types have an “adequate supply”. Rapid-acting insulin analogues were included in the SUS in 2017 following the approval of Conitec, the National Commission for the Implementation of Technologies in the Unified Health System.